Market Closed -
Other stock markets
|
Pre-market 05:55:52 pm | |||
303.3 USD | +1.56% | 302.8 | -0.14% |
14/06 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
14/06 | Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.30% | 163B | |
+51.82% | 797B | |
+40.57% | 628B | |
-6.88% | 351B | |
+16.95% | 323B | |
+9.49% | 300B | |
+17.00% | 244B | |
+0.94% | 223B | |
-6.29% | 153B | |
-2.18% | 118B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating